TRAW
Traws Pharma, Inc.
Key Financials
Net Income
$9.2M
↑ 105.5%
Operating Income
$-17875000
↑ 87.4%
Total Liabilities
$11.2M
↓ 80.1%
EPS (Diluted)
$0.82
↑ 102.3%
Total Assets
$10.6M
↓ 57.5%
Revenue
$2.8M
↑ 1134.5%
Shareholders' Equity
$11.6M
↑ 114.9%
Cash & Equivalents
$20.6M
↓ 46.6%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 10-K | 4/15/2026 | View on SEC |
| 8-K | 4/15/2026 | View on SEC |
| 8-K | 4/15/2026 | View on SEC |
| 4 | 4/8/2026 | View on SEC |
| 3 | 4/8/2026 | View on SEC |
| NT 10-K | 3/31/2026 | View on SEC |
| 4 | 3/10/2026 | View on SEC |
| 4 | 3/10/2026 | View on SEC |
| 4 | 3/10/2026 | View on SEC |
| 4 | 3/10/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | TRAW |
| Company Name | Traws Pharma, Inc. |
| CIK | 1130598 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 267-759-3680 |